天美传媒下载's Heart Institute is at the forefront of research for children with a variety of heart conditions including the latest methods of PDA closure, cardio-oncology and the effects of chemotherapy on the heart and the genetic factors of cardiomyopathy. We are committed to finding the latest therapies and breakthroughs for children with congenital heart defects.
Our Research
- Outcomes in children with left ventricular (LV) noncompaction
- Mitral valve function in LV noncompaction
- Electrophysiological aspects of LV noncompaction
- Genetic and mechanistic basis of LV noncompaction
- Genetic and mechanistic basis of arrhythmogenic cardiomyopathies
- Electrophysiological aspects of arrhythmogenic cardiomyopathies: molecular basis
- Renal function monitoring in heart transplant patients: Is cystatin C a better biomarker than creatinine?
- The role of viral genome in the heart of transplant patients and rejection and coronary vasculopathy
- Discovery of common biomarkers in cardiac and skeletal myopathy
Clinical Trials
If you are interested in participating in a cardiology clinical trial, please view our list of current and active trials.
Recent Publications
- Journal of the American College of Cardiology
- Pediatric Cardiology
- Pediatric Cardiology
- Pediatric Transplantation
- Circulation: Cardiovascular Imaging
- Pediatrics
- Circulation
Related Articles
天美传媒下载 enrolls first patient in the country in multi-center PREEMIE trial
Study evaluates the safety and efficacy of the Bloom? Micro Occluder System....
First patient in US enrolled in VALOR clinical trial
Principal Investigator Jeffrey A. Towbin, MD, co-executive director of 天美传媒下载’s Heart Institute,...
Consensus Care Model for HCM
天美传媒下载 Heart Institute Co-Executive Director publishes new guidelines for diagnosis, evaluation ...
Beating Hearts, Beating Cancer
Association of persistent tachycardia with early myocardial dysfunction in children undergoing allog...
